Leo Cancer Care is developing upright radiotherapy solutions leveraging research out of MD Anderson Cancer Centre. This research indicates better treatment plan results for 71% of typical patients treated in the upright position.
Leo Cancer Care is a company developing upright radiotherapy solutions.
As of May 2018, Indee Labs had accumulated more than USD$5.66.1 million dollars in angel, venture and non-dilutive capital.
The core technology, microfluidic vortex shedding (μVS), uses a microscopic fluid dynamics phenomenon based on vortex shedding to hydrodynamically porate the cell membrane allowing for the deliberate introduction of genetic material to human primary immune cells. Vortex shedding is not a new phenomenon. It can be observed as water flows past boulders in rivers while also being seen as clouds drift over mountains.
In July 2017, Indee Labs closed USD$1.3M in accelerator and angel financing from SOSV, IndieBio, Jude Gomila, Shaun Maguire, Y Combinator and Jaffray Woodriff (executed by his family office, Felton Group, LLC) among others.
As of May 2018, Indee Labs had accumulated more than USD$5.45.6 million dollars in angel, venture and non-dilutive capital.
In July 2017, Indee Labs closed USD$1.3M in accelerator and angel financing from Jude Gomila, Shaun Maguire, Y Combinator and Jaffray WoodriffJaffray Woodriff (executed by his family office, Felton Group, LLC) among others.
In July 2017, Indee Labs closed USD$1.3M in accelerator and angel financing from Jude Gomila, Shaun Maguire and, Y Combinator and Jaffray Woodriff (executed by his family office, Felton Group, LLC) among others.
In May 2018, Indee Labs closed out a seed round resulting in USD$2.6M in angel and venture financing from Founders FundFounders Fund, Main Sequence Ventures, Social+Capital also among others.
Indee Labs was founded onin August 16, 2015 with a 'mission to democratize gene-modified cell therapies' such as chimeric antigen receptor T cells (CAR-T). The team is developing a novel transfection technology that can rapidly and efficiently deliver a variety of genetic material (e.g., DNA, RNA, protein and/or various complexes) to human primary immune cells in seconds.
Government Grants
Non-dilutive Funding
As of AprilMay 20172018, Indee Labs had accumulated more than USD$4.45.4 million dollars in angel, venture and non-dilutive capital.
In FebruaryJuly 20162017, Indee Labs closed USD$550K1.3M in accelerator and angel financing from IndieBioJude Gomila, Shaun Maguire and SOSVY Combinator among others.
In March ofMay 20172018, Indee Labs kickedclosed offout a seed round resulting in USD$3M2.6M in angel and venture financing from JudeFounders GomilaFund, Shaun Maguire,Main YSequence CombinatorVentures, Social+Capital, Main Sequence Ventures and Founders Fundalso among others inclusive of refunds under an Overseas Finding for Australia's R&D Tax Incentive.